Jump to navigation
The latest clinical and political news for Australian oncologists
Dermatologists are concerned about the unlicensed product.
The checkpoint inhibitor has been approved for Hodgkin’s lymphoma.
It’s time to involve the patient and here’s how
Researchers say 40 years of data backs a fresh approach.
He wanted to prevent recurrence of prostate cancer.
Why patients need to be at the centre of cancer care
GPs are being urged to help women with breast cancer stick to their endocrine therapy.
One in 10 cancer patients have potentially futile treatment in their last two weeks of life.
Rejecting mainstream treatments appears particularly risky in breast cancer.
Do you have a story to tell? We’d love to hear from you
PBS approval for an expensive new drug raises an important question.
Treatment prompts practice rethink
He thought tumour would 'drop off'.
The telecoms company says Medicare data was corrupted.
Australia's primary screening program a world first.
The two genes differ in ovarian cancer risk.
Absolute mortality difference less than 1%.
Rapid diagnosis clinics needed says Cancer Council CEO
The unusual lymphoma has been classed as a 'distinct clinical entity'
But one practitioner has been cautioned
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.